Chauche Thierry 4

What Happened Thierry Chauche, Chief Financial Officer of Sagimet Biosciences (SGMT), sold 1,312 shares on February 10, 2026 at $5.36 per share, for proceeds of about $7,033. The filing (Form 4) was submitted on February 12, 2026. This transaction is a sale (routine) rather than a purchase.

Key Details

• Transaction date: 2026-02-10; Filing date: 2026-02-12 (appears timely under Form 4 rules).
• Price and size: 1,312 shares sold at $5.36 per share; total ≈ $7,033.
• Transaction type: Sale (code S); footnote indicates tax-withholding sale related to RSU vesting (automatic, not discretionary).
• Footnote: "Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units."
• Shares owned after transaction: Not specified in the provided excerpt.

Context This sale was executed to satisfy tax withholding on vested restricted stock units (RSUs). Such automatic withholding sales are common and are administrative in nature, not necessarily an indicator of the insider’s view on the company’s prospects.